Organon & Co | Ventes



Sales Changement Date
Adcock Ingram Holdings ZAR 4.9B 162.28M 2024-06
Bristol-Myers Squibb USD 12.34B 450M 2024-12
Celltrion KRW 1.06T 181.72B 2024-12
Cspc Pharmaceutical CNY 6.4B 899.68M 2024-09
Dianthus Therapeutics USD 2.17M 309K 2024-09
Ecofibre AUD 7.63M 1.27M 2024-06
Gilead Sciences USD 7.57B 24M 2024-12
Glaxosmithkline GBP 8.12B 105M 2024-12
Kangmei Pharma CNY 1.4B 126.12M 2024-09
Knight Therapeutics CAD 92.26M 3.31M 2024-09
Laboratorios Farma 178.16M 26.98M 2024-06
Malin Corporation EUR 19.2M 2.6M 2020-12
Medical Developments International AUD 7.54M 0 2023-12
Merck USD 15.62B 1.03B 2024-12
Neuren Pharmaceuticals AUD 194.1M 163.93M 2024-12
Novartis USD 13.56B 386M 2024-12
Organigram Holdings CAD 42.73M 1.97M 2024-12
Organon & Co 1.59B 8M 2024-12
Pharma Mar EUR 48.36M 2.71M 2024-12
Qiagen NV USD 499.93M 32.58M 2024-12
Sartorius EUR 907M 113.4M 2024-12
Sino Biopharmaceutical CNY 15.87B 592.96M 2024-06
Tilray USD 210.95M 10.91M 2024-11



Organon & Co Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.